Apogee Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating income | −$30.7M | −$93.0M | −$216.9M | −$285.6M |
| Net income | −$39.8M | −$84.0M | −$182.1M | −$255.8M |
| Operating cash flow | −$16.4M | −$74.8M | −$171.2M | −$227.4M |
| Free cash flow | none on file | −$74.9M | −$172.3M | −$232.6M |
| Cash | $151.9M | $118.3M | $141.8M | $131.5M |
| Shares outstanding | 0 | 48.3M | 58.1M | 68.4M |